The passing of the Misuse of Drugs (Medicinal Cannabis) Amendment Act means some products containing cannabidiol (CBD) are now prescription medicines only.
- Products that meet the definition of a CBD product (see below) are prescription medicines
- Ministry of Health approval is not required to prescribe, supply or administer products for medical purposes if they meet the definition of a CBD product
- Medical practitioners and pharmacies are allowed to import CBD products, as are persons or companies holding a licence to sell medicines by wholesale
- Individual patients may import CBD products provided they meet the requirements for importing prescription medicines (see below) but not any other cannabis based products
- A maximum of three months’ supply is allowed on a prescription for CBD products.
CBD is a substance found in cannabis that has potential therapeutic value, with little or no psychoactive properties.
Cannabidiol (CBD) is no longer a class B1 controlled drug under the Misuse of Drugs Act 1975. It is a prescription medicine under the Medicines Act 1981.
As with all prescription medicines, patients must have a prescription from an authorised prescriber to import or use CBD products. If you are interested in using CBD for a medical purpose, please talk to your doctor.
CBD is no longer a controlled drug. In addition, to increase access to CBD products, while minimising risks, a small amount of tetrahydrocannabinols and other psychoactive related substances are now permitted as contaminants in CBD products. In CBD products, the amount of tetrahydrocannabinols and psychoactive related substances must not exceed 2 percent of the total CBD tetrahydrocannabinol and psychoactive related substances content in the product.
This change to the control of CBD products is in response to advice the Government received from the Expert Advisory Committee on Drugs. It is important to note that medicinal cannabis products such as Sativex are not CBD products (refer Prescribing cannabis-based products).
Further information on prescribing medicinal cannabis and CBD products can be found on Prescribing cannabis-based products.
Bringing CBD products into New Zealand
No individual may leave or enter New Zealand with illicit cannabis, even if they have been diagnosed by a medical or nurse practitioner as requiring palliation. You can travel with 1 months’ supply of controlled drugs (eg, Sativex) or 3 months’ supply of prescription medicines (eg CBD products) provided you are able to show they have been lawfully supplied to you.
For further information on bringing medicines containing controlled drugs (eg Sativex) into New Zealand read Bringing medicines into New Zealand.
For further information on bringing medicines (eg CBD products) into New Zealand, refer to Medsafe’s website:
Pharmacies, authorised prescribers and licensed wholesalers of medicines are able to import CBD products, and are not required to have an import licence under the Misuse of Drugs Act.
There is a limited range of CBD products available
While the intent is to make it easier to access CBD products, there is currently a limited range of CBD products available in New Zealand. None of the products currently available have consent for distribution in New Zealand. Strict export restrictions on products sourced from some other countries will continue to impact the supply of CBD products in New Zealand. The range of products available in New Zealand is expected to increase once domestic cultivation and manufacture of medicinal cannabis products is enabled and established.